The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
Alongside brand refresh, the leading clinical trial technology company announces eConsent and eCOA offerings to better support the patient clinical trial journey
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
ChipCytometry delivers single-cell targeted spatial proteomics for complex whole-tissue analysis of the tumour microenvironment, as well as deep immune profiling for applications in immunology, neuroscience, and infectious disease
The availability of advanced SLED dialysis for critical patients, Plasmapheresis, CRRT machines along with ICCU dialysis complete the centre in every way
USFDA's industry recommendations and cancer Moonshot aim to improve lives of patients and their families
These results are being presented at the 2022 American Academy of Allergy, Asthma & Immunology (AAAAI) Annual Meeting
Eubio Isoquercetin derived from Sophora Japonica is expected to deliver more Quercetin to the body via small doses of Isoquercetin.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
The SureSTART consumables portfolio is designed for higher performance requirements, while meeting customer budgets
Subscribe To Our Newsletter & Stay Updated
